We also determined the effect of PLCE1 knockdown on the survival of cancer cells given with Paclitaxel and 5-FU, which are chemotherapeutic drugs commonly used for clinical treatment of ESCC. Here, PLCE1 is linked to esophageal squamous cell carcinoma.